Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab).

about

Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab).

Item

http://www.wikidata.org/entity/Q54974248

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Evaluation of the physicochemi ...... and diluted SB2 (infliximab).

@en

Evaluation of the physicochemi ...... reconstituted and diluted SB2

@nl

type

Item

label

Evaluation of the physicochemi ...... and diluted SB2 (infliximab).

@en

Evaluation of the physicochemi ...... reconstituted and diluted SB2

@nl

prefLabel

Evaluation of the physicochemi ...... and diluted SB2 (infliximab).

@en

Evaluation of the physicochemi ...... reconstituted and diluted SB2

@nl

P1476

Evaluation of the physicochemi ...... and diluted SB2 (infliximab).

@en

P2093

Dukwon Kang

http://www.w3.org/2001/XMLSchema#string

Jihyun Chung

http://www.w3.org/2001/XMLSchema#string

Jihyun Kim

http://www.w3.org/2001/XMLSchema#string

Saem Jung

http://www.w3.org/2001/XMLSchema#string

Sujin Park

http://www.w3.org/2001/XMLSchema#string

P2860

A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade(®)) in Healthy Subjects.

Evaluation of the physicochemical and functional stability of diluted REMSIMA® upon extended storage--A study compliant with NHS (UK) guidance.

A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.

Eliminating the use of intravenous glass bottles using a FOCUS-PDCA model and providing a practical stability reference guide.

Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins.

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/EJHPHARM-2016-001085

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29732144

http://www.w3.org/2001/XMLSchema#string

P932

5931250

http://www.w3.org/2001/XMLSchema#string